Globally, one of the most important cardiovascular diseases is acute coronary syndrome and is one of the leading causes of death, and its incidence is increasing among the elderly. Older adults are disproportionately affected by coronary ischemic heart disease; Indeed, it is believed that patients 65 years of age or older account for more than 60% of cases of ST-segment elevation myocardial infarctions (STEMIs). For many patients who report with STEMI, primary percutaneous coronary intervention (PCI) has replaced thrombolysis as the predominant revascularization method throughout the last ten years. Nevertheless, the provision of primary PCI within evidence-based timeframes is a difficult task, and levels of healthcare provision vary significantly across the globe. Consequently, even in the most favorable circumstances of a swift initial diagnosis, there is a possibility of lengthy transfer delays to the catheter laboratory. Variations in the chronology of patients' presentation and diagnosis can exacerbate these delays, which are detrimental to patient outcomes.